CME Group Inc. (NASDAQ:CME) Shares Purchased by Tokio Marine Asset Management Co. Ltd.

Key Points

• Tokio Marine Asset Management Co. Ltd. increased its stake in CME Group Inc. by 12% in the first quarter, now owning 11,013 shares worth approximately $2.92 million.
• Institutional investors currently hold 87.75% of CME Group's stock, with notable increases in holdings from firms like Price T Rowe Associates and GAMMA Investing.
• CME Group recently declared a quarterly dividend of $1.25 per share, reflecting an annualized dividend of $5.00 and a dividend yield of 1.8%.

Tokio Marine Asset Management Co. Ltd. boosted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 12.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,013 shares of the financial services provider's stock after buying an additional 1,177 shares during the quarter. Tokio Marine Asset Management Co. Ltd.'s holdings in CME Group were worth $2,922,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in CME. Bank Pictet & Cie Europe AG lifted its holdings in CME Group by 29.0% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock worth $20,190,000 after buying an additional 19,533 shares in the last quarter. Advisory Services Network LLC boosted its stake in CME Group by 15.5% during the 4th quarter. Advisory Services Network LLC now owns 1,609 shares of the financial services provider's stock valued at $374,000 after acquiring an additional 216 shares during the last quarter. Mariner LLC boosted its stake in CME Group by 4.3% during the 4th quarter. Mariner LLC now owns 98,052 shares of the financial services provider's stock valued at $22,770,000 after acquiring an additional 4,024 shares during the last quarter. Aware Super Pty Ltd as trustee of Aware Super bought a new position in CME Group during the 4th quarter valued at $2,086,000. Finally, Guggenheim Capital LLC boosted its stake in CME Group by 7.4% during the 4th quarter. Guggenheim Capital LLC now owns 18,603 shares of the financial services provider's stock valued at $4,320,000 after acquiring an additional 1,283 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CME shares. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Citigroup increased their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. JPMorgan Chase & Co. reduced their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research note on Thursday, April 24th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research note on Thursday, April 24th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $261.93.

CME Group Stock Performance

Shares of CME stock traded down $0.78 during trading hours on Friday, reaching $273.92. The stock had a trading volume of 2,055,786 shares, compared to its average volume of 2,086,143. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a twelve month low of $204.16 and a twelve month high of $290.79. The firm has a 50-day simple moving average of $275.52 and a 200-day simple moving average of $267.37. The firm has a market capitalization of $98.72 billion, a PE ratio of 26.52, a price-to-earnings-growth ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter last year, the company earned $2.56 EPS. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Insiders Place Their Bets

In related news, Director Charles P. Carey sold 500 shares of the stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the sale, the general counsel directly owned 6,708 shares in the company, valued at approximately $1,861,470. This trade represents a 5.49% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,450 shares of company stock worth $676,663. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.